Sunitinib malate for the treatment of renal cell carcinoma

By Wood Lori  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1323-1336

Informa Healthcare

Access to resources Recommend Favorite

Sunitinib malate for the treatment of pancreas malignancies – where does it fit?

By Mankal Pavan   O'Reilly Eileen  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 783-792

Informa Healthcare

Access to resources Recommend Favorite

Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial

By Reynolds Craig   Spira Alexander   Gluck Larry   Bradie-Muller Suzanne   Zhan Feng   Boehm Kristi   Asmar Lina  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1628-1628

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

By Shirao Kuniaki   Nishida Toshirou   Doi Toshihiko   Komatsu Yoshito   Muro Kei   Li Yinhua   Ueda Eiji   Ohtsu Atsushi  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 866-875

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin Based Chemotherapy in the Treatment of Advanced Urothelial Cancer with Poor Prognostic Features

By Guerrero-Urbano T.   Norman A.   Lau F.N.   Horwich A.   Dearnaley D.P.   Huddart R.A.  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 87-91

Ashgate Publishing Ltd

Access to resources Recommend Favorite